NLS Pharmaceutics Announces New In-Vitro Data Reconfirming Quilience's(R) (Mazindol ER) Unique Dual Mechanism of Action Involving Significant Orexin-2 Receptor Activity

Stock Information for NLS Pharmaceutics Ltd.

Loading

Please wait while we load your information from QuoteMedia.